3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
33
Lymphoma
25
Lymphoma, Large B-Cell, Diffuse
19
Lymphoma, Non-Hodgkin
12
Leukemia
9
Hodgkin Disease
9
Burkitt Lymphoma
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Multiple Myeloma
8
Lymphoma, Mantle-Cell
8
Lymphoma, Follicular
8
Carcinoma, Non-Small-Cell Lung
8
Ovarian Neoplasms
7
Sarcoma
6
Neoplasms
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Triple Negative Breast Neoplasms
5
Neutropenia
5
Lymphoma, B-Cell, Marginal Zone
5
Central Nervous System Neoplasms
5
Urinary Bladder Neoplasms
4
Prostatic Neoplasms
4
Osteosarcoma
4
Lung Neoplasms
4
Waldenstrom Macroglobulinemia
3
Testicular Neoplasms
3
Sarcoma, Ewing
3
Rhabdomyosarcoma
3
Neuroblastoma
3
Neoplasm Metastasis
3
Interventions
Trastuzumab
19
pyrotinib
14
pertuzumab
8
Docetaxel
7
Paclitaxel
6
Capecitabine
4
Carboplatin
3
neratinib
2
Protons
2
Neoadjuvant Therapy
2
Fulvestrant
2
Ado-Trastuzumab Emtansine
2
tucatinib
1
trastuzumab deruxtecan
1
pegfilgrastim
1
palbociclib
1
inavolisib
1
exemestane
1
envafolimab
1
dalpiciclib
1
atezolizumab
1
Taxoids
1
Metformin
1
Leuprolide
1
Letrozole
1
Isovaleryl-CoA Dehydrogenase
1
Goserelin
1
Genetic Testing
1
Fluorodeoxyglucose F18
1
Enfuvirtide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
HER2-positive Breast Cancer
×
pegfilgrastim
×
Clear all
NCT03571633
2025-11-26
BREASTIMMU02
Centre Leon Berard
Phase 2
Active not recruiting
90 enrolled